# A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors

> **NCT01608867** · PHASE1 · COMPLETED · sponsor: **OncoMed Pharmaceuticals, Inc.** · enrollment: 26 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **BIOLOGICAL:** OMP-54F28

## Key facts

- **NCT ID:** NCT01608867
- **Lead sponsor:** OncoMed Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2016-08
- **Final completion:** 2017-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2020-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01608867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01608867, "A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01608867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*